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Nogo-A is an important neurite growth-regulatory protein in the adult and developing ner-
vous system. Mice lacking Nogo-A, or rats with neuronal Nogo-A deficiency, exhibit behav-
ioral abnormalities such as impaired short-term memory, decreased pre-pulse inhibition,
and behavioral inflexibility. In the current study, we extended the behavioral profile of the
Nogo-A deficient rat line with respect to reward sensitivity and motivation, and determined
the concentrations of the monoamines dopamine and serotonin in the prefrontal cortex
(PFC), dorsal striatum (dSTR), and nucleus accumbens (NAcc). Using a limited access con-
sumption task, we found similar intake of a sweet condensed milk solution following ad libi-
tum or restricted feeding in wild-type and Nogo-A deficient rats, indicating normal reward
sensitivity and translation of hunger into feeding behavior. When tested for motivation in
a spontaneous progressive ratio task, Nogo-A deficient rats exhibited lower break points
and tended to have lower “highest completed ratios.” Further, under extinction conditions
responding ceased substantially earlier in these rats. Finally, in the PFC we found increased
tissue levels of serotonin, while dopamine was unaltered. Dopamine and serotonin lev-
els were also unaltered in the dSTR and the NAcc. In summary, these results suggest a
role for Nogo-A regulated processes in motivated behavior and related neurochemistry.
The behavioral pattern observed resembles aspects of the negative symptomatology of
schizophrenia.
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INTRODUCTION
Nogo-A is an important neurite growth-regulatory protein in
the developing and adult nervous system (Schwab, 2010). While
research originally focused on oligodendrocytic Nogo-A and its
role in injury and repair of fiber tracts in the CNS, the fact that
Nogo-A was found to be present also in neurons (Huber et al.,
2002) has risen interest in its involvement in the generation of
general behavior, as well. Indeed, in a wide-ranging analysis, Willi
et al. (2009, 2010) could demonstrate behavioral alterations in
Nogo-A knockout (Nogo-A−/−) mice.
Recently, Nogo-A deficiency could be established in the rat
species by using a transgenic, constitutively expressed artificial
microRNA leading to a 50% reduction of Nogo-A levels in neurons
(Tews et al., 2013). Similar to Nogo-A−/−mice, these Nogo-A defi-
cient rats exhibited a variety of behavioral deficits, such as reduced
pre-pulse inhibition of the acoustic startle response, behavioral
inflexibility, and impairments in short-term memory. In addition,
pronounced alterations in social behavior were found. Conduct-
ing basic research or preclinical studies in rats offer the advantage
that, for example, they more readily learn difficult cognitive behav-
ioral tasks and exhibit more complex social behaviors than mice
(Poole and Fish, 1975; McNamara et al., 1996; Costantini and
D’Amato, 2006; Cressant et al., 2007). Further, the rat Nogo-A
knockdown model uses the well-characterized Sprague Dawley
outbred strain and therefore offers increased translational value
compared to inbred mice, which is particularly important when
evaluating a possible role of neuronal growth regulation in psychi-
atric disorders (Tews et al., 2013). This latter point is of interest, as
the behavioral and structural phenotypes of Nogo-A−/− mice and
Nogo-A deficient rats make them potential tools to investigate the
pathology of schizophrenia (SCZ; Kristofikova et al., 2013; Willi
and Schwab, 2013).
Schizophrenia is a common and debilitating psychiatric disor-
der and believed to result from neurodevelopmental disturbances
(Keshavan et al., 2008; Tandon et al., 2008; Lewis and Sweet,
2009). Interestingly, neuronal Nogo-A is highly expressed particu-
larly during early neuronal development and down regulated later
during adulthood in most regions, except the hippocampus, sug-
gesting an important role in neuronal network formation (Huber
et al., 2002; Kempf and Schwab, 2013; Mironova and Giger, 2013).
In the current study, we aimed to investigate the consequences
of Nogo-A deficiency with respect to two important aspects of
the negative spectrum of SCZ symptoms, which have not yet been
explored in rats nor in mice: avolition, a decrease in the motivation
to take action and pursue goals, and anhedonia, the reduced abil-
ity to experience positive affect through reward (Tandon et al.,
2009). The negative symptoms of SCZ have been particularly
linked to genetic liability and neurodevelopmental disturbances
(Dominguez et al., 2010). Further, it has been described before that
interference with neuronal development by lesioning the neonatal
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brain can affect reward sensitivity (Le Pen et al., 2002) or motivated
behavior (Schneider and Koch, 2005).
Motivational states in rats can be made accessible to quantifica-
tion by the use of operant progressive ratio schedules introduced
by Hodos and colleagues (Hodos, 1961; Hodos and Kalman, 1963).
In this test, subjects need to exhibit progressively increasing effort
(more lever pressing) to gain a stable amount of reward; the oper-
ant demand at which reward-related responding ceases is termed
the “break point” and can serve as an index for reinforcer efficacy
or a rat’s motivational state (Barr and Phillips, 1998; Reilly, 1999;
Mobini et al., 2000). In the Nogo-A deficient rat, we employed
the spontaneous progressive ratio test (PR-Test) and addition-
ally assessed operant responding under extinction conditions, i.e.,
when rewards were completely omitted. Reward sensitivity was
investigated in a well-validated limited access consumption task for
sweet rewards (Enkel et al., 2010; Schneider et al., 2010). Finally, to
relate behavioral findings to underlying neurochemistry, we ana-
lyzed dopamine and serotonin (5-HT) content in brain regions
associated with reward processing, namely nucleus accumbens
(NAcc), dorsal striatum (dSTR), and prefrontal cortex (PFC).
MATERIALS AND METHODS
All experiments in this study were performed in accordance with
national and international ethical guidelines, conducted in com-
pliance with the German Animal Welfare Act and approved by the
local authorities (Regierungspräsidium Karlsruhe, Germany).
SUBJECTS
Male, heterozygous Nogo-A deficient rats (Nogo-A KD rats) of
the previously characterized and described transgenic line SD-
Tg(CAG-RNAi:Nogo-A,EGFP)2ZI (Tews et al., 2013; L2 rats) and
wild-type littermates (WT rats) were bred at the animal facil-
ities of the Central Institute of Mental Health, Mannheim. At
the beginning of the study they were 8 months old. They were
housed in groups of three to four animals per cage under con-
trolled conditions [22°C, 12 h light-dark cycle (lights-on at 7 a.m.),
constant humidity]. Throughout the experiments, water was avail-
able ad libitum and food was restricted to 20 g/rat/day. Each rats’
bodyweight was controlled continuously not to fall below 90%
of free-feeding weight. Experiments were performed during the
light phase between 09:00 and 12:00. Before the start of behavioral
assessments, all rats were handled for 5 min daily on five consecu-
tive days. For behavioral analysis, 18 rats were initially used but 1
rat from the WT group consumed neither the milk used as reward
in the experiments nor any other food outside its home cage and
it was therefore excluded from the study, resulting in the following
group sizes: Nogo-A KD: n= 9; WT: n= 8. Group sizes in neuro-
chemical experiments were: Nogo-A KD: n= 15; WT: n= 9; this
cohort consisted of randomly chosen animals from the current
study and age-matched animals used in a previous study (Tews
et al., 2013).
CONSUMPTION TEST
Prior to the consumption test sessions, rats were given free access to
the reward [a 25% solution of sweetened condensed milk (SCM),
Milchmaedchen, Nestle Germany] in their home cage to reduce
any neophagia. On the day preceding testing, rats were separated
in small cages (type 3) for 1 h. Testing for SCM intake took place
24 h later in these cages. After 5 min of habituation, rats had access
to a drinking bottle containing the SCM solution for 15 min. The
amount of liquid consumed was recorded for each rat by weighing
the bottle before and after 5 and 15 min of drinking time. Consume
was calculated in relation to the individual body weight. The test
was conducted twice, while rats were under the restricted feeding
schedule (i.e., in hungry rats) and following overnight ad libitum
feeding prior to the consumption test (i.e., in non-hungry rats).
OPERANT CONDITIONING PROCEDURES
All operant schedules were carried out in four identical rat oper-
ant training chambers (MedAssociates, Vermont, USA) controlled
by a computer running MedPC-IV software and custom-made
MedStat Notation code. During sessions, a fan provided constant
background noise; sessions always started with illumination of the
houselight, which remained on until the session was finished. On
the first 2 days, rats received 30 min session of magazine train-
ing (levers retracted) in which the dispenser used to deliver 60µl
SCM was manually operated 10–15 times; at the end of the sec-
ond session all rats reliably drank from the food trough. Magazine
training was followed by acquisition of lever pressing under a con-
tinuous reinforcement schedule (fixed ratio 1). Each trial started
with extension of the response lever. Pressing the lever resulted in
its retraction and delivery of 60µl of SCM; once a rat entered the
food trough to consume the reward, the lever was extended for
the next trial. Training continued with the so-called “lever access
training,” in which rats were required to nose poke into a newly
installed response device on the opposite wall of the lever to ini-
tiate lever extension. All training sessions ended after 30 min or
when 60 rewards had been earned (whatever occurred first). Once
all rats showed stable trial initiation and responding, the PR-Test
was performed. In a single session (fixed to 30 min duration) the
operant demand was progressively increased such that the num-
ber of lever presses required to receive a reward was raised by one
following each reward delivery (i.e., a dwell 1-step 1 sequence).
Following measures were taken: (1) the ratio in which a first inac-
tivity phase of 180 s occurred; this ratio was termed the “break
point,” (2) the highest completed ratio achieved within the 30-
min session, (3) the latencies to respond on the lever after insertion
(response latency), and (4) to consume the reward after delivery
(consume latency). Note that after a break point had occurred, a
rat was allowed to continue to press the lever for the whole 30 min
duration of the session (i.e., the“highest completed ratio”achieved
could be higher than or identical to the break point). One day after
the PR-Test, lever pressing was tested in a single session under
extinction conditions, i.e., all lever presses were unrewarded. To
control for activity changes during this session an additional lever
with no programed consequences was inserted into the chamber
and the numbers of lever presses on both levers were recorded.
Both levers were present throughout the session and therefore no
nose poking was required.
NEUROCHEMISTRY
After decapitation under carbon dioxide anesthesia brains were
removed, immediately frozen in isopentane, wrapped in alu-
minum foil, and stored at−80°. Using a cryotome (Leica, Nußloch,
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Germany), 120µm thick frontal sections were cut and brain tissue
was dissected from the PFC (from+4.7 to+3.0 mm from Bregma;
including medial and orbitofrontal parts), dSTR (from +2.2 to
−1.7 mm from Bregma; caudate putamen), and NAcc (from+2.7
to +0.8 mm from Bregma, including NAcc core and shell sub-
regions) using punching needles; respective brain regions were
identified according to the Rat Brain Atlas by Paxinos and Wat-
son (2007). Frozen tissue samples were collected in polypropylene
tubes and stored at−80° until further processing.
For HPLC analysis samples were thawed, weighed, and imme-
diately homogenized in an extraction solution (0.1 M perchloric
acid, 1 mM EDTA) using a tissue homogenizer Mixer Mill (Qia-
gen, Hilden, Germany). Yielded solutions were subsequently cen-
trifuged at 15000× g for 10 min at 4°C. Cleared supernatants
were analyzed by a HPLC system consisting of a Triathlon
autosampler (Spark Holland B.V., Emmen, Netherlands), a Shi-
madzu LC-10 AD pump (Shimadzu Corporation, Kyoto, Japan), a
150 mm× 2.1 mm C18-Reprosil-AQ reverse phase column (3µm
particle size; Dr. Maisch HPLC GmbH, Ammerbuch, Germany)
and a Decade II electrochemical detector (Antec Leyden, Zoeter-
woude, Netherlands). The mobile phase was 50 mM sodium cit-
rate, 2.4 mM sodium octyl sulfate, 0.1 mM EDTA, 10 mM NaCl,
and 22% methanol at pH 4.0. The temperature applied on the
system was 37°C. Tissue concentrations were determined by nor-
malizing the quantified amounts of respective neurotransmitters
and their metabolites to the corresponding weight of the individual
tissue sample.
STATISTICS
Sweetened condensed milk intake was analyzed using a three-
way repeated measure ANOVA with factors drinking time
(5/15 min)× feeding status (restricted/ad libitum)× genotype
(Nogo-A/WT) and post hoc paired t -Tests (two-tailed) where
appropriate. For operant behavior, lever press activity during
training sessions was analyzed as number of trials per minute
due to varying session lengths; for the PR-Test, data were ana-
lyzed as completed ratios (for example, a ratio of “12” required 12
lever presses to be completed); under extinction, the exact number
of lever presses made was taken for analysis. Behavioral parame-
ters and neurotransmitter content were compared using two-tailed
Student’s t -test or, in cases of unequal variances, Welch’s t -Test.
Calculations were done with SPSS statistical software (Version 21,
IBM Corporation). In all cases p-values of 5% or lower (p≤ 0.05)
were accepted as statistically significant.
RESULTS
REWARD SENSITIVITY
No significant differences were found between the groups of
rats regarding their bodyweight on the day before the first con-
sumption test (Nogo-A KD: 632g± 12; WT:648 g± 16; t 15= 0.79,
p= 0.45). Figure 1 shows the amount of SCM consumed after
5 or 15 min access to the drinking bottle under each feed-
ing status (restricted/ad libitum). There was no main effect
of the factor genotype (F 1,15= 0.85, p= 0.372) and none of
the other factors (feeding state or drinking time) interacted
with genotype (all p> 0.660), indicating that Nogo-A KD
rats consumed similar amounts compared to WT controls
FIGURE 1 | Reward sensitivity in Nogo-A deficient rats. There were no
differences in SCM intake between Nogo-A KD and WT rats under any
feeding condition or at any time point. Restricted feeding prior to the
consumption test resulted in higher SCM intake after 5 min (p<0.001) and
15 min (p< 0.001). Data are expressed as means±SEM. WT: n=8, Nogo-A
KD: n=9. Asterisks (*) indicate statistically significant differences.
under each condition. Significant main effects were found
for feeding state (F 1,15= 158.78, p< 0.001) and drinking time
(F 1,15= 457.37, p< 0.001), and these two factors interacted sig-
nificantly (F 1,15= 113.71, p< 0.001); further inspection of the
data indicated that, after restricted feeding rats consumed more
total SCM in 15 min (t 16= 12.91, p< 0.001) and they also con-
sumed more SCM during the first 5 min of drinking time following
restricted compared to ad libitum feeding (t 16= 4.87, p< 0.001).
MOTIVATION
Acquisition of operant responding during the initial learning stage
(days 1–5), and the performance during the “lever access” stage
(days 6–8; nose poking required to access lever) was similar in
both strains (Figure 2A). Explicitly, a planned comparison of
the number of initiated trials during the last training session
before the PR-Test (Figure 2A, day 8) confirmed that there was
no statistically relevant difference between Nogo-A KD and WT
rats (Nogo-A KD: 2.3± 0.3 trials/min, WT: 2.9± 0.2 trials/min;
t 15= 1.56, p= 0.139). During the PR-Test (Figure 2B), Nogo-
A KD rats exhibited a significantly lower break point (Nogo-A
KD: 17± 2.8, WT: 24± 1.4; t 11.87= 2.19, p= 0.049) and, addi-
tionally, a tendency for a decreased “highest completed ratio” was
found in Nogo-A KD rats (Nogo-A KD: 18± 2.6, WT: 24± 1.2;
t 11.22= 1.87, p= 0.088). Further, response latencies were signifi-
cantly increased in Nogo-A KD rats compared to WTs (Nogo-A
KD: 6.7s± 1.1, WT: 3.4 s± 0.3; t 8.94= 3.04, p= 0.014), but con-
sumption latencies were similar between groups (Nogo-A KD:
2.8 s± 0.7, WT: 2.1 s± 0.4; t 11.78= 0.88, p= 0.398; Figure 2C).
Under the extinction schedule, i.e., when lever pressing was no
longer rewarded, responding ceased earlier in Nogo-A KD rats
than in WT rats (Figure 2D). While this was apparent for the pre-
viously rewarded lever (Nogo-A KD: 9.3± 1.5, WT: 17.3± 1.6;
t 15= 3.59, p= 0.003), this was not the case for the alterna-
tively available new lever (Nogo-A KD: 7.0± 2.1, WT: 9.4± 1.9;
t 15= 0.83, p= 0.419) on which rats from both groups made less
responses compared to the previously rewarded lever.
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FIGURE 2 | Motivational behavior in Nogo-A deficient rats.
(A) Nogo-A KD rats acquired operant responding similar to WT rats (days
1–5); additionally, there was no difference in baseline performance before
the PR-Test (during days 6–8, when nose poking was required to get
access to the lever). (B) In the PR-Test, Nogo-A KD rats had a
significantly lower break point (p=0.049) and tended to have a lower
“highest completed ratio” (p= 0.088). (C) Response latency was
increased in Nogo-A KD rats (p=0.014) while the latency to consume
the SCM was unaltered (p=0.398). (D) Performance under extinction
conditions. Nogo-A KD rats made significantly less lever presses than
WT rats on the trained lever (p=0.003). There was no difference for the
untrained lever (p=0.419). Data are expressed as means±SEM. WT:
n=8, Nogo-A KD: n=9. Asterisks (*) indicate statistically significant
differences, the number sign (#) indicates a trend.
NEUROCHEMISTRY
Concentrations of monoamine neurotransmitters and their
metabolites in tissue homogenates from PFC, dSTR, and
NAcc of Nogo-A KD and WT rats are shown in Table 1.
We found a highly significant 25% increase in 5-HT tis-
sue levels in the PFC (WT:1.37± 0.07 pmol/mg, Nogo-A:
1.71± 0.08 pmol/mg; t 22= 2.895, p= 0.008) while the metabo-
lite 5-Hydroxyindoleacetic acid (5-HIAA) was not altered. No
further significant alterations of DA or its metabolites 3,4-
dihydroxyphenylacetic acid (DOPAC) or homovanillic acid (HVA)
or of 5-HT or its metabolite 5-HIAA were detected in any other
brain region measured.
DISCUSSION
Deficiency of the Nogo-A protein,which is highly expressed during
neurodevelopment (Huber et al., 2002), has been associated with a
variety of behavioral abnormalities in adult rats (Tews et al., 2013).
Here, we extended the behavioral profile of Nogo-A deficient rats
with respect to reward sensitivity and motivation.
Consumption of a palatable SCM solution was taken as an indi-
cator for reward sensitivity. This test has been shown to be sensitive
to detect anhedonic states, for example, due to blockade of the opi-
oid system (Schneider et al., 2010) or due to stress in an animal
model of depression (Enkel et al., 2010). Intake after ad libitum
pre-feeding with lab chow assumingly reflects mainly the hedonic
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PFC WT 0.20±0.03 0.15±0.01 0.19±0.03 0.81±0.09 1.12±0.35 1.37±0.07 1.68±0.27 1.27±0.25
Nogo-A 0.17±0.02 0.13±0.01 0.23±0.02 1.25±0.33 2.03±0.50 1.72±0.08** 1.63±0.10 0.96±0.06
dSTR WT 45.88±4.34 10.23±1.04 2.50±0.28 0.24±0.03 0.06±0.01 1.51±0.21 2.40±0.23 1.66±0.11
Nogo-A 43.27±2.16 12.01±1.16 2.83±0.39 0.28±0.072 0.06±0.01 1.40±0.11 2.34±0.19 1.69±0.07
NAcc WT 15.36±2.23 6.28±1.21 1.56±0.36 0.41±0.06 0.10±0.02 1.49±0.26 2.03±0.31 1.44±0.21
Nogo-A 14.46±1.66 5.68±0.56 1.37±0.15 0.43±0.04 0.10±0.01 1.76±0.21 2.25±0.14 1.52±0.20
5-HT levels were significantly increased in the PFC.
Data are expressed as means±SEM. **p=0.008; WT: n=9, Nogo-A: n=15
component of the reward, whereas intake after restricted feeding
has an added component of hunger; indeed, when rats were hun-
gry SCM intake was higher and more rapid. Nevertheless, under
both conditions Nogo-A KD rats consumed similar amounts of
SCM compared to WT and also the time pattern of consumption
was similar, implying normal reward sensitivity and translation
of hunger into feeding behavior. Our data therefore show that
reduced levels of Nogo-A do not affect sensitivity to food rewards.
Of course, anhedonia in other domains, e.g., for social reward,
cannot be excluded.
Some studies interfering with neurodevelopmental processes
have reported unaltered reward sensitivity, but found motivational
deficits (Schneider and Koch, 2005). Correspondingly, Nogo-A
KD rats exhibited pronounced motivational deficits under a pro-
gressive ratio schedule of operant responding. They had a lower
break point, indicating that in these rats a “drop” in their moti-
vation to engage in effortful lever pressing occurred earlier, i.e., at
lower operant demands. Although some Nogo-A KD rats contin-
ued to press the lever after the break point had occurred, they
were not willing to invest similar amounts of effort to obtain
as much rewards as WT rats, as suggested by the tendency for
a decreased “highest completed ratio.” Importantly, inspection of
the time courses of responding verified that the 30-min session
duration did not pose time constraints on the animals; rather, ani-
mals from both groups were inactive during the last minutes of
the session. After initiating a trial by nose poking, Nogo-A KD
rats were slower to actually begin lever pressing but not to con-
sume the reward once achieved, supporting the interpretation of
a motivational deficit but normal reward sensitivity. Our results
are not likely to be confounded by impaired learning, since WT
and Nogo-A KD rats acquired lever pressing similarly and there
were no baseline performance differences between groups prior
to the PR-Test, or by decreased locomotor activity, since normal
explorative behavior has been shown for Nogo-A KD rats (Tews
et al., 2013).
From the current study, the functional origin of the moti-
vational deficit cannot be definitely concluded. Our data allow
excluding anhedonia as an explanation, given normal SCM con-
sumption and normal consumption latencies in the PR-Test, but
instead suggest disturbances in the instrumental phase of moti-
vated behavior. The latter refers to several processes required to
translate reward information into goal-directed behavior, such as
“wanting,” cost-benefit calculation and response initiation, which
are more difficult to disentangle (Salamone and Correa, 2012).
The fact that Nogo-A KD rats still initiated trials by nose pok-
ing to access the lever and performed lever pressing to a certain
extent suggests normal response initiation. Further, this also sug-
gests that the reward was still “wanted”and that a representation of
the reward could be used to motivate them to start a new trial. But
there are some hints that in Nogo-A KD rats either the represen-
tation of reward value itself or its use in cost/benefit calculations
could indeed be altered. Interesting in this respect is a comparison
of the performance in the PR-Test with the extinction session. In
both groups, lever pressing ceased earlier under extinction con-
ditions than in the PR-Test, but this effect was much stronger in
Nogo-A KD rats. The main difference between these sessions is
that during extinction any lever pressing is solely dependent on
a representation of the reward (since no rewards can be phys-
ically experienced), while during the PR-Test the action-reward
interval increases progressively and provides at least some hedo-
nic experience (some rewards are delivered). Importantly, on the
(never rewarded) control lever both groups made comparably
few responses excluding overall lower activity in Nogo-A KD rats
during extinction as an alternative explanation.
Our study also collected neurochemical data related to moti-
vational processes. Although, our analysis of tissue monoamine
levels under baseline conditions does not allow drawing sub-
stantial conclusions about direct functional relationships between
altered monoaminergic activity and behavior, these data neverthe-
less provide some indirect information on the processes potentially
contributing to the motivational deficit. Dopamine has been par-
ticularly linked to “wanting” and cost/benefit calculations (Sala-
mone et al., 2007; Salamone and Correa, 2012) and the fact that
we found no alterations in the dopaminergic transmitter system
was surprising, but appears to be in line with our above discussed
observation that Nogo-A KD rats were still wanting the reward. Of
particular interest is therefore the highly significant increase in pre-
frontal 5-HT levels in Nogo-A KD rats. Increased brain seroton-
ergic tone, due to deletion of the serotonin transporter or chronic
5-HT reuptake blockade, has been shown to decrease motivation
for natural rewards in mice (Sanders et al., 2007). Particularly
intriguing, increased serotonergic tone in the orbitofrontal areas
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of the PFC has been specifically associated with impaired ability
to use the value of expected outcomes to guide behavior (Nonkes
et al., 2010). This suggests that the motivational deficit in Nogo-A
KD rats could indeed be a consequence of the observed alter-
ations of 5-HT levels in the PFC. Brain microdialysis experiments
monitoring transmitter release in the behaving rat could provide
such correlative information. Alternatively, alterations in transmit-
ter systems other than the dopaminergic or serotonergic systems
could of course contribute to the motivational deficit. For exam-
ple, the glutamatergic and GABAergic systems, which could not
be measured in this study, have also been linked to motivational
processes (Faure et al., 2010).
The findings of this study are of considerable interest given that
reward-related disturbances are clinical features of many psychi-
atric disorders (Brown and Pluck, 2000), e.g., of the negative symp-
toms of SCZ which have been particularly linked to genetic liabil-
ity and neurodevelopmental disturbances (Tandon et al., 2009;
Dominguez et al., 2010). In our study Nogo-A KD rats did not
show deficits in reward sensitivity; although anhedonia – which is
defined as the decreased capacity to experience pleasure – has long
been considered a symptom in SCZ, more recent research supports
the idea that hedonic processing itself is indeed normal in patients
but that cognitive deficits instead lead to negatively biased self-
report about hedonic experience (Strauss and Gold, 2012). More
important in this respect is that the motivational deficit in Nogo-A
KD rats resembles avolition, which is defined as a lack in the moti-
vation to pursue goals. Avolition is commonly seen in patients
with SCZ and has always been considered a core negative symp-
tom (Tandon et al., 2009; Messinger et al., 2011). Furthermore,
an increase in serotonergic neurotransmission is suggested to be
present in schizophrenic patients (Ngan et al., 2000; Dean, 2003).
Our current results are therefore in line with earlier reports link-
ing the behavioral phenotype of Nogo-A deficient rats (Tews et al.,
2013), or of Nogo-A−/− mice (Willi et al., 2010), to a variety of
schizophrenic symptoms.
The fact that the rats used in the current study and by Tews
et al. (2013) were deficient of Nogo-A in neurons, but not in
oligodendrocytes, allows an interesting comparison with earlier
work in mice which bear the Nogo-A knockout in both cell types
(Willi et al., 2010). Similar to these mice, Nogo-A KD rats exhibit
behavioral deficits such as reduced pre-pulse inhibition of the
acoustic startle response, behavioral inflexibility, impairments in
short-term memory and impairments in management of reference
frames (Tews et al., 2013; Petrasek et al., 2014). Additionally, they
show the motivational deficits demonstrated in the current study.
Given the cell-type specific temporal expression profile of Nogo-
A, with high expression of Nogo-A in neurons mainly during early
development and high expression in oligodendrocytes mainly in
the postnatal nervous system, the behavioral deficits observed
in the Nogo-A deficiency rat model and the Nogo-A−/− mouse
model appear to be largely the consequences of disturbed brain
developmental processes following Nogo-A deficiency particu-
larly in neurons. Indeed, Nogo-A has been shown to be critically
involved in early cortical development and neuronal maturation
(Mingorance-Le Meur et al., 2007). This is intriguing since SCZ
is considered to be a disorder of abnormal neurodevelopment
(Lewis and Sweet, 2009). Notably, we found some clear differences
between Nogo-A KD rats and Nogo-A−/− mice regarding alter-
ations in neurotransmission: in contrast to rats, Nogo-A−/− mice
had reduced tissue levels of DA and its metabolites DOPAC and
HVA in the dSTR. Additionally, no reductions in tissue levels of
5-HT were found (Willi et al., 2010). Whether these differences to
rats are related to the additional lack of oligodendrocytic Nogo-A
in mice is unclear. Yet, since oligodendrocytic Nogo-A is crucial
for myelination, which continues postnatally, ongoing perturba-
tions in neuronal development might lead to the differential out-
come in Nogo-A KD rats and Nogo-A−/− mice. Alternatively, in
Nogo-A−/− mice compensatory upregulation of Nogo-B has been
reported (Willi et al., 2010), an effect not present in Nogo-A defi-
cient rats (Tews et al., 2013). More research is needed to determine
possible differential contributions of neuronal or oligodendro-
cytic Nogo-A to the behavioral and neurochemical phenotypes
observed. The Nogo-A deficiency rat model nevertheless provides
a promising tool to complement the Nogo-A−/− mouse model to
further elucidate the role of Nogo-A in neuropsychiatric disorders
like SCZ.
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